Spyre Therapeutics, Inc. Common Stock (SYRE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for SYRE. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 13,026,187 | $1.2B | INCREASED |
| BlackRock | 6,506,605 | $578M | INCREASED |
| Vanguard | 6,423,758 | $570M | INCREASED |
| Perceptive Advisors | 4,319,496 | $383M | INCREASED |
| Rtw Investments | 4,251,996 | $377M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Cameron Turtle (Chief Executive Officer) | SELL | 400 | $36K | 2026-09-01 |
| Cameron Turtle (Chief Executive Officer) | SELL | 3,700 | $326K | 2026-09-01 |
| Cameron Turtle (Chief Executive Officer) | SELL | 8,400 | $732K | 2026-09-01 |
| Cameron Turtle (Chief Executive Officer) | SELL | 2,500 | $216K | 2026-09-01 |
| Scott L Burrows (Chief Financial Officer) | EXERCISE | 7,500 | $109K | 2026-09-01 |
Full institutional holdings, insider history, and congressional trades for Spyre Therapeutics, Inc. Common Stock on SentiSense.